WVE
NASDAQ HealthcareWave Life Sciences Ltd. - Ordinary Shares
Biotechnology
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
๐ Market Data
| Price | $5.09 |
|---|---|
| Volume | 3,236,503 |
| Market Cap | 1.00B |
| Beta | -1.290 |
| RSI (14-Day) | 36.3 |
| 200-Day MA | $9.49 |
| 50-Day MA | $5.85 |
| 52-Week High | $21.73 |
| 52-Week Low | $5.01 |
| Forward P/E | -4.28 |
| Price / Book | 1.84 |
๐ฏ Investment Strategy Scores
WVE scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (98/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Over-Hyped (16/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find WVE in your text
Paste any article, transcript, or post โ the tool will extract WVE and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.